Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F0B0G
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,957
Award facts
- Contract value 100% obligated
- $19,956.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $19,956.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 30, 2026, for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. The contract is scheduled for completion by February 2, 2026, with performance taking place at the contractor's Conshohocken, Pennsylvania location. This delivery order was competitively awarded with no set-aside designation and serves as a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at up to $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (UEI: NWEGNLYTBDW4), is a major pharmaceutical distributor providing critical medical supply support to military healthcare systems and federal agencies. The BIKTARVY order supports military and veteran healthcare procurement needs through DLA's medical supply chain. As a prime vendor under the DLA Troop Support Medical indefinite delivery vehicle, AmerisourceBergen maintains capability to supply a comprehensive range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F0B0G?
SPE2DR26F0B0G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F0B0G worth?
The government has obligated $19,957 on SPE2DR26F0B0G.
Is contract SPE2DR26F0B0G an order under another contract?
Yes. SPE2DR26F0B0G is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F0B0G competed?
The extent of competition for SPE2DR26F0B0G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award